• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

英国停用镇痛药复方羟考酮对非致命性自杀的影响。

Impact of withdrawal of the analgesic Co-proxamol on nonfatal self-poisoning in the UK.

机构信息

Centre for Suicide Research, Department of Psychiatry, University of Oxford, UK.

出版信息

Crisis. 2011;32(2):81-7. doi: 10.1027/0227-5910/a000063.

DOI:10.1027/0227-5910/a000063
PMID:21602162
Abstract

BACKGROUND

In early 2005 the UK Committee on Safety of Medicines (CSM) announced gradual withdrawal of the analgesic co-proxamol because of its adverse benefit/safety ratio, especially its use for intentional and accidental fatal poisoning. Prescriptions of co-proxamol were reduced in the 3-year withdrawal phase (2005 to 2007) following the CSM announcement.

AIMS

To assess the impact of the CSM announcement in January 2005 to withdraw co-proxamol on nonfatal self-poisoning with co-proxamol and other analgesics.

METHODS

Interrupted time series analysis of general hospital presentations for nonfatal self-poisoning (five hospitals in three centers in England), comparing the 3-year withdrawal period 2005-2007 with 2000-2004.

RESULTS

A marked reduction in the number of episodes of nonfatal self-poisoning episodes involving co-proxamol was found following the CSM announcement (an estimated 62% over the period 2005 to 2007 compared to 2000 to 2004). There was no evidence of an increase in nonfatal self-poisoning episodes involving other analgesics (co-codamol, codeine, co-dydramol, dihydrocodeine, and tramadol) in relation to the CSM announcement over the same period, nor a change in the number of all episodes of self-poisoning.

LIMITATIONS

Data were from three centers only.

CONCLUSIONS

The impact of the policy appears to have reduced nonfatal self-poisoning with co-proxamol without significant substitution with other analgesics. This finding is in keeping with that for suicide.

摘要

背景

2005 年初,英国药物安全委员会(CSM)宣布逐步撤回镇痛药复方羟考酮,因其不良的获益/风险比,尤其是其被用于故意和意外致命中毒。在 CSM 发布公告后,复方羟考酮的处方在 3 年的撤药阶段(2005 年至 2007 年)减少。

目的

评估 2005 年 1 月 CSM 宣布撤回复方羟考酮对非致命性自我中毒用复方羟考酮和其他镇痛药的影响。

方法

采用中断时间序列分析,对英格兰三个中心的五家医院的非致命性自我中毒(5 家医院)进行分析,比较 2005-2007 年的 3 年撤药期与 2000-2004 年。

结果

在 CSM 宣布之后,非致命性自我中毒的事件数量明显减少,涉及复方羟考酮(与 2000 年至 2004 年相比,2005 年至 2007 年期间估计减少了 62%)。在同一时期,没有证据表明与 CSM 公告相关的涉及其他镇痛药(复方可待因、可待因、复方双氢可待因、二氢可待因和曲马多)的非致命性自我中毒事件增加,也没有改变自我中毒的总事件数量。

局限性

数据仅来自三个中心。

结论

该政策的影响似乎降低了非致命性自我中毒用复方羟考酮的发生,而没有明显替代其他镇痛药。这一发现与自杀一致。

相似文献

1
Impact of withdrawal of the analgesic Co-proxamol on nonfatal self-poisoning in the UK.英国停用镇痛药复方羟考酮对非致命性自杀的影响。
Crisis. 2011;32(2):81-7. doi: 10.1027/0227-5910/a000063.
2
Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: time-series study.英格兰和威尔士停用可待因复方片对处方和死亡的 6 年随访:时间序列研究。
PLoS Med. 2012;9(5):e1001213. doi: 10.1371/journal.pmed.1001213. Epub 2012 May 8.
3
Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: time series analysis.在英格兰和威尔士,撤用复方丙氧氨酚对处方开具及药物中毒死亡的影响:时间序列分析
BMJ. 2009 Jun 18;338:b2270. doi: 10.1136/bmj.b2270.
4
Relative toxicity of analgesics commonly used for intentional self-poisoning: A study of case fatality based on fatal and non-fatal overdoses.常用镇痛药自杀中毒的相对毒性:基于致死性和非致死性过量中毒的病例死亡率研究。
J Affect Disord. 2019 Mar 1;246:814-819. doi: 10.1016/j.jad.2019.01.002. Epub 2019 Jan 4.
5
ECG abnormalities in co-proxamol (paracetamol/dextropropoxyphene) poisoning.复方氨酚右丙氧芬(对乙酰氨基酚/右丙氧芬)中毒时的心电图异常
Clin Toxicol (Phila). 2005;43(4):255-9.
6
Suicides involving co-proxamol fell dramatically after withdrawal in UK.在英国,含双醋瑞因的自杀事件在其撤市后大幅下降。
BMJ. 2012 May 9;344:e3255. doi: 10.1136/bmj.e3255.
7
Co-proxamol and suicide: a study of national mortality statistics and local non-fatal self poisonings.复方丙氧氨酚与自杀:一项基于全国死亡率统计数据及地方非致命性自我中毒情况的研究
BMJ. 2003 May 10;326(7397):1006-8. doi: 10.1136/bmj.326.7397.1006.
8
Co-proxamol withdrawal has reduced suicide from drugs in Scotland.在苏格兰,停用复方丙氧氨酚已减少了药物所致自杀事件。
Br J Clin Pharmacol. 2008 Aug;66(2):290-3. doi: 10.1111/j.1365-2125.2008.03206.x. Epub 2008 Apr 21.
9
Co-proxamol and suicide: preventing the continuing toll of overdose deaths.复方丙氧氨酚与自杀:防止过量用药死亡人数持续攀升
QJM. 2005 Mar;98(3):159-70. doi: 10.1093/qjmed/hci026.
10
Use of analgesics in intentional drug overdose presentations to hospital before and after the withdrawal of distalgesic from the Irish market.在爱尔兰市场停用痛力克前后,医院收治的故意药物过量患者中镇痛药的使用情况。
BMC Clin Pharmacol. 2010 Mar 18;10:6. doi: 10.1186/1472-6904-10-6.

引用本文的文献

1
Development of a Self-Harm Monitoring System for Victoria.维多利亚自残监测系统的开发。
Int J Environ Res Public Health. 2020 Dec 15;17(24):9385. doi: 10.3390/ijerph17249385.
2
Impact of medicines regulatory risk communications in the UK on prescribing and clinical outcomes: Systematic review, time series analysis and meta-analysis.英国药品监管风险沟通对处方和临床结果的影响:系统评价、时间序列分析和荟萃分析。
Br J Clin Pharmacol. 2020 Apr;86(4):698-710. doi: 10.1111/bcp.14104. Epub 2019 Dec 16.
3
Cardiomyocytes from human pluripotent stem cells: From laboratory curiosity to industrial biomedical platform.
源自人类多能干细胞的心肌细胞:从实验室的新奇事物到工业生物医学平台。
Biochim Biophys Acta. 2016 Jul;1863(7 Pt B):1728-48. doi: 10.1016/j.bbamcr.2015.10.014. Epub 2015 Oct 31.
4
Citalopram and cardiac toxicity.西酞普兰与心脏毒性。
Eur J Clin Pharmacol. 2013 Apr;69(4):755-60. doi: 10.1007/s00228-012-1408-1. Epub 2012 Sep 21.
5
Current status of drug screening and disease modelling in human pluripotent stem cells.人类多能干细胞中的药物筛选和疾病建模的现状。
Bioessays. 2013 Mar;35(3):281-98. doi: 10.1002/bies.201200053. Epub 2012 Aug 8.
6
Six-year follow-up of impact of co-proxamol withdrawal in England and Wales on prescribing and deaths: time-series study.英格兰和威尔士停用可待因复方片对处方和死亡的 6 年随访:时间序列研究。
PLoS Med. 2012;9(5):e1001213. doi: 10.1371/journal.pmed.1001213. Epub 2012 May 8.